Physician

Stanton S Lebouitz, M.D.

According to 2025 Medicare claims, Stanton Lebouitz, M.D. (NPI: 1255322798) practices dermatology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is PENNSYLVANIA DERMATOLOGY PARTNERS INC (NPI: 1023382918; TIN: 454600640) and primary practice location at 17402-4745.

Lebouitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,520 traditional Medicare patients, billed 11,226 HCPCS/CPT codes, and received $355,607 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 4,149 prescription claims across 1,217 beneficiaries totaling $1,635,497 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 146 records totaling $2,931. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $707,822 to $1,635,497. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,434	12,378	$488,177
2016	2,358	12,053	$455,540
2017	2,377	12,067	$455,254
2018	2,224	11,650	$466,214
2019	2,177	10,841	$448,736
2020	1,911	9,782	$374,923
2021	1,864	10,749	$390,663
2022	1,756	11,504	$345,383
2023	1,501	11,773	$336,986
2024	1,520	11,226	$355,607

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,538	5,123	$707,822
2016	1,414	4,748	$685,369
2017	1,404	4,726	$671,534
2018	1,470	4,960	$999,776
2019	1,456	5,013	$1,041,843
2020	1,173	4,435	$1,049,520
2021	1,121	4,018	$1,064,569
2022	1,205	3,919	$1,044,552
2023	1,210	4,066	$1,431,664
2024	1,217	4,149	$1,635,497

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17004	Destruction of precancer skin growth, 15 or more growths	464	669	$112
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,123	1,915	$60
17000	Destruction of precancer skin growth, 1 growth	829	1,198	$41
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	285	417	$30
17003	Destruction of precancer skin growth, 2-14 growths	701	4,859	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	24	896	$325,211
Skyrizi Pen	Risankizumab-Rzaa	15	1,036	$314,485
Otezla	Apremilast	43	1,290	$217,078
Cosentyx Unoready Pen	Secukinumab	12	350	$144,919
Cosentyx Sensoready (2 Pens)	Secukinumab	15	420	$109,693

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	146	$2,931	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stanton S. Lebouitz, M.D.?

Tedicare shows public-source Medicare data for Stanton S. Lebouitz, M.D. (NPI 1255322798), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stanton S. Lebouitz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stanton S. Lebouitz, M.D.?

Stanton S. Lebouitz, M.D. is linked to PENNSYLVANIA DERMATOLOGY PARTNERS INC (billing NPI 1023382918) in the available physician profile data.

Does Stanton S. Lebouitz, M.D. have Open Payments data?

Stanton S. Lebouitz, M.D. has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.